Dandi Raises $1.3M For its Fertility Care Platform That Enhances IVF Treatment With Patient Support – AlleyWatch
Summary
After connecting with hundreds of women, it became undeniably clear that there was a very consistent set of pain points being experienced by this patient population, and a real opportunity to develop tailored solutions to start to improve the fertility care experience. We began our journey to create the first line of products built specifically for the IVF injection experience.During this time, I was connected with Leyla Bilali (cofounder), a registered nurse and fertility specialist with over a decade of clinical experience. Dandi is also piloting several B2B solutions with its partners to create operational efficiencies in their patient care models.How are you preparing for a potential economic slowdown?Unfortunately, demand for IVF does not appear to be slowing down as more people are forced to rely on it to bring a child into the world. With a single cycle of IVF costing $15k-$30k, Dandi has positioned its care solutions as relatively low-cost offerings that can have an outsized impact with so much at stake.What was the funding process like?From day 1, our north star was to align with partners who understood the importance of Danids mission. We turned this headwind into a tailwind channeling our energy to managing every dollar meticulously with laser focus on an expedited path to profitability.What factors about your business led your investors to write the check?Our raise was as much about forging connection over a deeply challenging human experience, as it was anything else.